A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION OF MORBIDITY AND MORTALITY IN ADULTS WITH OBESITY (SURMOUNT-MMO)

Intervention/treatment:
TIRZEPATIDE (LY3298176)
Medical condition:
OBESITY
Protocol code:
I8F-MC-GPIJ
Control number:
267218
Status:
Active, not recruiting
Approved:
September 23, 2022
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT05556512
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
40 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Sponsor
ELI LILLY CANADA INC

Locations

Alpha Recherche Clinique
Québec, G2J 0C4
ALPHA Recherche Clinique
Québec, G3K 2P8
Bluewater Clinical Research Group Inc.
Sarnia, N7T 4X3
C-health Research
Calgary, T2V 4J2
Centre de Medecine Metabolique de Lanaudiere (CMML)
Terrebonne, J6X 4P7
Centricity Research Oshawa
Oshawa, L1J 2K9
Diabetes Heart Research Centre
Toronto, M6G 1M2
Dr. Anil K. Gupta Medicine Professional Corporation
Toronto, M9V 4B4
Dr. M.B. Jones Inc.
Victoria, V8V 4A1
Ecogene-21
Chicoutimi, G7H 7K9
Fraser Clinical Trials Inc
New Westminster, V3L 3W4
G A Research Associates
Moncton, E1G 1A7
Health Sciences North
Greater Sudbury, P3E 5J1
LMC Clinical Research Inc. (Bayview)
Toronto, M4G 3E8
LMC Clinical Research Inc. (Brampton)
Brampton, L6S 0C6
Manna Research
Lévis, G6W 0M5
Manna Research Montreal
Pointe-Claire, H9R 4S3
Medicor Research
Greater Sudbury, P3C 1X3
Med Trust Research
Courtice, L1E 2J5
North York Diagnostic and Cardiac Centre
North York, M6B 3H7
NSHA-QEII Health Sciences Centre-Dickson Bldg
Halifax, B3H 1V7
Power Clinical Research
Montreal, H3M 1L3
Premier Clinical Trial Network
Hamilton, L8L 5G4
Synergy Medical Clinic
Sherwood Park, T8H 0N2
The Wharton Medical Clinic Clinical Trials Inc
Hamilton, L8L 5G8
Viacar Recherche Clinique
Greenfield Park, J4V 2G8
Did you find what you were looking for?